Risk factors associated with adverse drug events among older adults in emergency department.

BACKGROUND Little is known about the emergency department (ED) visits from drug-related injury among older adults in Taiwan. This study seeks to identify risk factors associated with adverse drug events (ADEs) leading to ED visits. METHODS We prospectively conducted a case-control study of patients 65years and older presenting to the ED. ED visits between March 1, 2009 and Feb 28, 2010 identified by investigators for suspected ADEs were further assessed by using the Naranjo Adverse Drug Reaction probability scale. For each patient with an ADE, a control was selected and time-matched from the ED population of the study hospital. The association between the risk of adverse drug events and triage, age, gender, serum alanine transaminase (ALT), serum creatinine, number of medications, and Charlson Comorbidity Index scores were analyzed using logistic regression. RESULTS Of 20,628 visits, 295 ADEs were physician-documented in older adults. Independent risk factors for ADEs included number of medications (adjusted odds ratio [OR]=4.1; 95% confidence interval [CI] 2.4-6.9 for 3-7 drugs; adjusted OR=6.4; 95% CI 3.7-11.0 for 8 or more drugs) and increased concentration of serum creatinine (adjusted OR=1.5; 95% CI 1.1-2.2). Diuretics, analgesics, cardiovascular agents, anti-diabetic agents and anticoagulants were the medications most commonly associated with an ADE leading to ED visits. CONCLUSIONS This study suggests that prevention efforts should be focused on older patients with renal insufficiency and polypharmacy who are using high risk medications such as anticoagulants, diuretics, cardiovascular agents, analgesics, and anti-diabetic agents.

[1]  M. Afilalo,et al.  Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[2]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[3]  P. Barach,et al.  Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting , 2004, Annals of Internal Medicine.

[4]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.

[5]  C. Holman,et al.  Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. , 2007, British journal of clinical pharmacology.

[6]  J. Avorn,et al.  Drug prescribing for the elderly. , 1986, Archives of internal medicine.

[7]  Paula Rochon,et al.  Improving the quality of medication use in elderly patients: a not-so-simple prescription. , 2002, Archives of internal medicine.

[8]  D. Greenblatt,et al.  A method for estimating the probability of adverse drug reactions , 1981, Clinical pharmacology and therapeutics.

[9]  A. Flahault,et al.  Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. , 1993, Journal of clinical epidemiology.

[10]  K. Brune,et al.  Cytochrome P450 Polymorphisms in Geriatric Patients , 2005, Drugs & aging.

[11]  P. Neuvonen,et al.  Drug-related deaths in a university central hospital , 2002, European Journal of Clinical Pharmacology.

[12]  Daniel J. Kent,et al.  A pharmacist-based screening program of octogenarians starting new medications. , 2003, Journal of managed care pharmacy : JMCP.

[13]  D. L. Le Couteur,et al.  Aging Biology and Geriatric Clinical Pharmacology , 2004, Pharmacological Reviews.

[14]  M. Beers,et al.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. , 2003, Archives of internal medicine.

[15]  S. Yusuf,et al.  Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.

[16]  F. Lu,et al.  Use of the Beers Criteria to Predict Adverse Drug Reactions Among First‐Visit Elderly Outpatients , 2005, Pharmacotherapy.

[17]  Erratum to: Adverse Drug Reactions and Impaired Renal Function in Elderly Patients Admitted to the Emergency Department , 2013, Drugs & Aging.

[18]  D. Pollock,et al.  Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system. , 2005, Annals of emergency medicine.

[19]  J. de Lemos,et al.  Emergency hospitalizations for adverse drug events. , 2012, The New England journal of medicine.

[20]  G. Trifirò,et al.  Adverse drug events in emergency department population: a prospective Italian study , 2005, Pharmacoepidemiology and drug safety.

[21]  C. Bénichou Criteria of drug-induced liver disorders. Report of an international consensus meeting. , 1990, Journal of hepatology.

[22]  H. Sox,et al.  Clinical prediction rules. Applications and methodological standards. , 1985, The New England journal of medicine.

[23]  Matthew H Samore,et al.  Risk Factors for Adverse Drug Events: A 10-Year Analysis , 2005, The Annals of pharmacotherapy.

[24]  S. Haider,et al.  Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 - 2002. , 2007, International journal of clinical pharmacology and therapeutics.

[25]  M. Ducharme,et al.  Drug-Induced Alterations in Serum Creatinine Concentrations , 1993 .

[26]  U. Bergman,et al.  Adverse Drug Reactions and Impaired Renal Function in Elderly Patients Admitted to the Emergency Department , 2009, Drugs & aging.

[27]  K. Johnell,et al.  Inappropriate Drug Use in the Elderly: a Nationwide Register-Based Study , 2007, The Annals of pharmacotherapy.

[28]  D. Bates,et al.  Risk Factors for Adverse Drug Events Among Older Adults in the Ambulatory Setting , 2004, Journal of the American Geriatrics Society.

[29]  John W Hafner,et al.  Adverse drug events in emergency department patients. , 2002, Annals of emergency medicine.

[30]  C. Richards,et al.  Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults , 2007, Annals of Internal Medicine.

[31]  E. Eldesoky,et al.  Pharmacokinetic-Pharmacodynamic Crisis in the Elderly , 2007, American journal of therapeutics.

[32]  J. Rothschild,et al.  Analysis of risk factors for adverse drug events in critically ill patients* , 2012, Critical care medicine.

[33]  Graziano Onder,et al.  Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. , 2010, Archives of internal medicine.

[34]  F. Haramburu,et al.  Does age increase the risk of adverse drug reactions? , 2002, British journal of clinical pharmacology.

[35]  D. Bates,et al.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting. , 2003, JAMA.

[36]  Brenda Tipper,et al.  The impact of polypharmacy on the health of Canadian seniors. , 2012, Family practice.

[37]  D. Bates,et al.  Risk factors for adverse drug events among nursing home residents. , 2001, Archives of internal medicine.

[38]  J K McLaughlin,et al.  Selection of controls in case-control studies. I. Principles. , 1992, American journal of epidemiology.

[39]  J K McLaughlin,et al.  Selection of controls in case-control studies. III. Design options. , 1992, American journal of epidemiology.

[40]  E. Oren,et al.  Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. , 2001, JAMA.

[41]  C. Richards,et al.  Emergency Hospitalization for Adverse Drug Events in Older Americans , 2012 .

[42]  Y. Chen,et al.  Detection of patients presenting with adverse drug events in the emergency department , 2012, Internal medicine journal.

[43]  C. Richards,et al.  Emergency hospitalizations for adverse drug events in older Americans. , 2011, The New England journal of medicine.

[44]  U. Meyer Pharmacogenetics and adverse drug reactions , 2000, The Lancet.

[45]  S. Schroeder,et al.  How Many Hours Is Enough? An Old Profession Meets a New Generation , 2004, Annals of Internal Medicine.

[46]  M. Gallo,et al.  Regional surveillance of emergency-department visits for outpatient adverse drug events , 2009, European Journal of Clinical Pharmacology.

[47]  U. Sarkar,et al.  Adverse drug events in U.S. adult ambulatory medical care. , 2011, Health services research.